B‐type natriuretic peptide over N‐terminal pro‐brain natriuretic peptide to predict incident atrial fibrillation after cryptogenic stroke

• Published in: European journal of neurology Vol. 28; no. 2; pp. 540 - 547
• Main Authors: Palà, E., Pagola, J., Juega, J., Francisco‐Pascual, J., Bustamante, A., Penalba, A., Comas, I., Rodriguez, M., De Lera Alfonso, M., Arenillas, J. F., Torres, R., Pérez‐Sánchez, S., Cabezas, J. A., Moniche, F., González‐Alujas, T., Molina, C. A., Montaner, J.
• Format: Journal Article
• Language: English
• Published: England John Wiley & Sons, Inc 01.02.2021
• Subjects: atrial fibrillation; Biomarkers; BNP; Brain; Brain natriuretic peptide; Cardiac arrhythmia; Confidence intervals; cryptogenic stroke; Fibrillation; Immunoassays; Monitoring; NT‐proBNP; Peptides; Prediction models; Quartiles; Stroke; atrial fibrillation; NT-proBNP; cryptogenic stroke; BNP; biomarkers

Background and purpose B‐type natriuretic peptide (BNP) and N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) are well‐known surrogates of atrial fibrillation (AF) detection but studies usually present data on either BNP or NT‐proBNP. The aim was to determine and directly compare the validity of...